Skip to Main Content

Author Details

Giuseppe Giaccone
Meyer Cancer Center
1981
659
107
PMIDPaper TitleJournal TitlePublished Year
37774950The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2024
37774950The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2024
36791474Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.J Clin Oncol2023
37634808The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Proposal for the T Component for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2023
37704166Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.Ann Oncol2023
37702630The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: An Overview of the Central Database Informing Revision of the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2023
37689391The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposal for a Stage Classification for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2023
37689390The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: A Re-Assessment of the International Thymic Malignancy Interest Group/International Association for the Study of Lung Cancer Lymph Node Map for Thymic Epithelial Tumors for the Forthcoming Ninth Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2023
37611726Advances in biology and novel treatments of SCLC.Semin Cancer Biol2023
37244438Current knowledge of small cell lung cancer transformation from non-small cell lung cancer.Semin Cancer Biol2023
37236329Advancements in small cell lung cancer.Semin Cancer Biol2023
36791474Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.J Clin Oncol2023
37634808The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Proposal for the T Component for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2023
37704166Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.Ann Oncol2023
37702630The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: An Overview of the Central Database Informing Revision of the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2023
37611726Advances in biology and novel treatments of SCLC.Semin Cancer Biol2023
37689391The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposal for a Stage Classification for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2023
37689390The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: A Re-Assessment of the International Thymic Malignancy Interest Group/International Association for the Study of Lung Cancer Lymph Node Map for Thymic Epithelial Tumors for the Forthcoming Ninth Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2023
37244438Current knowledge of small cell lung cancer transformation from non-small cell lung cancer.Semin Cancer Biol2023
37236329Advancements in small cell lung cancer.Semin Cancer Biol2023
34393062Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.Clin Lung Cancer2022
36246734Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations.Onco Targets Ther2022
36049655A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.J Thorac Oncol2022
35972744Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials: A Systematic Review and Meta-analysis.JAMA Netw Open2022
35961945Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials.Expert Opin Investig Drugs2022
35649819Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy.Clin Lung Cancer2022
36096156Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.Lancet Oncol2022
35750053Sex and cancer immunotherapy: Current understanding and challenges.Cancer Cell2022
36402755Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.Cell Death Dis2022
35598361The regulation of CD73 in non-small cell lung cancer.Eur J Cancer2022
36578277High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.Adv Radiat Oncol2022
37014168Reply to Dr. Goto's Letter: "A Thymoma Mouse Model Harboring a Gtf2i L424H Mutation".J Thorac Oncol2022
35321838The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2022
34580031Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report.Clin Lung Cancer2022
34393062Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.Clin Lung Cancer2022
34876673Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine.Br J Cancer2022
35649819Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy.Clin Lung Cancer2022
35598361The regulation of CD73 in non-small cell lung cancer.Eur J Cancer2022
35750053Sex and cancer immunotherapy: Current understanding and challenges.Cancer Cell2022
37014168Reply to Dr. Goto's Letter: "A Thymoma Mouse Model Harboring a Gtf2i L424H Mutation".J Thorac Oncol2022
36402755Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.Cell Death Dis2022
36578277High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.Adv Radiat Oncol2022
35972744Association of Anticancer Immune Checkpoint Inhibitors With Patient-Reported Outcomes Assessed in Randomized Clinical Trials: A Systematic Review and Meta-analysis.JAMA Netw Open2022
36246734Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations.Onco Targets Ther2022
35961945Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials.Expert Opin Investig Drugs2022
36096156Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.Lancet Oncol2022
36049655A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.J Thorac Oncol2022
34876673Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine.Br J Cancer2022
35321838The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors.J Thorac Oncol2022
34580031Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report.Clin Lung Cancer2022
  • 1 - 50 of 1,318

Recommended Authors

Philip E Lammers
Baptist Cancer Center
Career Start Year 2013
Number of shared co-authors 1
Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 2
Gareth Rivalland
Auckland City Hospital
Career Start Year 2010
Number of shared co-authors 1
Sara Kuruvilla
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2010
Number of shared co-authors 2
Puey Ling Chia
Lee Kong Chian School of Medicine, Nanyang Technological University
Career Start Year 2009
Number of shared co-authors 2
Caroline E McCoach
UCSF Helen Diller Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 8
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Career Start Year 2008
Number of shared co-authors 4
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 4
Bhumsuk Keam
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 3
Paul Wheatley-Price
The Ottawa Hospital Research Institute
Career Start Year 2005
Number of shared co-authors 3
Shubham Pant
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Matthew A Gubens
University of California san francisco
Career Start Year 2003
Number of shared co-authors 8
Shane White
Olivia Newton-John Cancer Wellness and Research Centre
Career Start Year 2000
Number of shared co-authors 5
Daniel Morgensztern
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 11
Collin M Blakely
University of California san francisco
Career Start Year 1998
Number of shared co-authors 7
Michael Bergqvist
Umea University
Career Start Year 1998
Number of shared co-authors 0
Cheryl Ho
University of British Columbia
Career Start Year 1995
Number of shared co-authors 5
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 9
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 7
Jonathan W Goldman
David Geffen School of Medicine at university of california los angeles
Career Start Year 1991
Number of shared co-authors 12
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 2
Dean A Fennell
University of Leicester
Career Start Year 1990
Number of shared co-authors 7
Joan Albanell
Hospital del Mar Research Institute
Career Start Year 1990
Number of shared co-authors 1
Val??rie Laurence
Institut Curie
Career Start Year 1990
Number of shared co-authors 1
Allan Zimet
Epworth Hospital
Career Start Year 1988
Number of shared co-authors 1
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 6
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 8
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 10
Robert H Shoemaker
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 9
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 5

Collaborators

Arun Rajan
Center for Cancer Research, National Cancer Institute
Co-authored papers 50
Jose Antonio Rodriguez
University of the Basque Country (UPV/EHU)
Co-authored papers 38
Yisong Wang
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 36
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 19
Iacopo Petrini
University of Pisa
Co-authored papers 16
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Co-authored papers 13
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 13
Andrew G Nicholson
Co-authored papers 12
Bhaskar Kallakury
Georgetown University
Co-authored papers 10
Roy S Herbst
Yale School of Medicine
Co-authored papers 8
Donna Voeller
Center for Cancer Research, National Cancer Institute
Co-authored papers 7
Jonathan K Killian
From Foundation Medicine
Co-authored papers 7
Udayan Guha
Co-authored papers 6
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Trung Pham
Stanford University
Co-authored papers 6
David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Jan H M Schellens
Department of Pharmaceutical Sciences, Utrecht University
Co-authored papers 5
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Co-authored papers 5
David J Liewehr
Center for Cancer Research
Co-authored papers 5
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers 5
Pasi A J??nne
Dana-Farber Cancer Institute
Co-authored papers 5
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 4
Liang Cao
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Mariaelena Pierobon
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 4
Garrett T Graham
Co-authored papers 4
Paul J van Diest
University Medical Center Utrecht
Co-authored papers 4
Zied Abdullaev
Co-authored papers 4
Patricia S Steeg
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Release 1.2